Topicort Spray Approved to Treat Plaque Psoriasis
Taro Pharmaceuticals announced that it has received approval from the FDA for its New Drug Application (NDA) for Topicort (desoximetasone) Topical Spray.
Topicort is a corticosteroid indicated for the treatment of plaque psoriasis in patients >18 years old. Topical corticosteroids possess anti-inflammatory, antipruritic and vasoconstrictive actions to treat various skin disorders.
Topicort Topical Spray will be available in a 0.25% strength. Other Topicort products include Topicort Ointment (desoximetasone 0.25%), Topicort Gel (desoximetasone 0.05%), and Topicort-LP Cream (desoximetasone 0.05%).
For more information call (800) 544-1449 or visit www.taro.com.